First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection
Authors:
- 26 April 2023
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 50 (9) , 2802-2817
Abstract
Purpose Claudin 18.2 (CLDN18.2) is a reliable target for lesion detection and could have clinical implications for epithelial tumors, especially digestive system neoplasms. However, there is no predictive technology for accurate whole-body mapping of CLDN18.2 expression in patients. This study assessed the safety of the 124I-18B10(10L) tracer and the feasibility of mapping whole-body CLDN18.2 expression using PET functional imaging. Methods The 124I-18B10(10L) probe was synthesized manually, and preclinical experiments including binding affinity and specific targeting ability were conducted after testing in vitro model cells. Patients with pathologically confirmed digestive system neoplasms were enrolled in an ongoing, open-label, single-arm, first-in-human (FiH) phase 0 trial (NCT04883970). 124I-18B10(10L) PET/CT or PET/MR and 18F-FDG PET were performed within one week. Results 124I-18B10(10L) was successfully constructed with an over 95% radiochemical yield. The results of preclinical experiments showed that it had high stability in saline and high affinity in CLDN18.2 overexpressing cells (Kd = 4.11 nM). Seventeen patients, including 12 with gastric cancers, 4 with pancreatic cancers, and 1 with cholangiocarcinoma were enrolled. 124I-18B10(10L) displayed high uptake in the spleen and liver, and slight uptake in the bone marrow, lung, stomach and pancreas. The tracer uptake SUVmax in tumor lesions ranged from 0.4 to 19.5. Compared with that in lesions that had been treated with CLDN18.2-targeted therapy, 124I-18B10(10L) uptake was significantly higher in lesions that had not. Regional 124I-18B10(10L) PET/MR in two patients showed high tracer uptake in metastatic lymph nodes. Conclusions 124I-18B10(10L) was successfully prepared and exhibited a high binding affinity and CLDN18.2 specificity in preclinical studies. As an FiH CLDN18.2 PET tracer, 124I-18B10(10L) was shown to be safe with acceptable dosimetry and to clearly reveal most lesions overexpressing CLDN18.2. Trial registration NCT04883970; URL: https://register.clinicaltrials.gov/. Registered 07 May 2021.Keywords
Funding Information
- National Natural Science Foundation of China (82171980, 82171973, 82102091, 82072728)
- Beijing Hospitals Authority’ Ascent Plan (DFL20191102)
- Beijing Millions of Talent Projects A level funding (No. 2019A38)
- The Pilot Project (4 th Round) to Reform Public Development of Beijing Municipal Medical Research Institute (2021-1)
This publication has 27 references indexed in Scilit:
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancerNature Medicine, 2018
- Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancerNature Communications, 2018
- Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric CancerJNCI: Journal of the National Cancer Institute, 2018
- A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancerEuropean Journal of Cancer, 2018
- Tight junctions: from simple barriers to multifunctional molecular gatesNature Reviews Molecular Cell Biology, 2016
- Claudins and the Modulation of Tight Junction PermeabilityPhysiological Reviews, 2013
- Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT TrialJournal of Clinical Oncology, 2013
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody DevelopmentClinical Cancer Research, 2008
- claudin-18 , a Novel Downstream Target Gene for the T/EBP/NKX2.1 Homeodomain Transcription Factor, Encodes Lung- and Stomach-Specific Isoforms through Alternative SplicingMolecular and Cellular Biology, 2001
- Multifunctional strands in tight junctionsNature Reviews Molecular Cell Biology, 2001